title: Effects of human arylamine N-acetyltransferase I knockdown in triple-negative breast cancer cell lines.
abstract: Expression of human arylamine N-acetyltransferase I (NAT1) has been associated with various cancer subtypes and inhibition of this enzyme with small molecule inhibitors or siRNA affects cell growth and survival. Here, we have investigated the role of NAT1 in the invasiveness of breast cancer cells both in vitro and in vivo. We knocked down NAT1 using a lentivirus-based shRNA approach and observed marked changes in cell morphology in the triple-negative breast cancer cell lines MDA-MB-231, MDA-MB-436, and BT-549. Most notable was a reduction in the number and size of the filopodia protrusions on the surface of the cells. The loss of filopodia could be rescued by the reintroduction of NAT1 into the knockdown cells. NAT1 expression was localized to the lamellipodia and extended into the filopodia protrusions. In vitro invasion through Geltrex was significantly inhibited in both the MDA cell lines but not in the BT-549 cells. The expression of Snail increased when NAT1 was knocked down, while other genes associated with mesenchymal to epithelial transition (vimentin, cytokeratin-18, and Twist) did not show any changes. By contrast, both N-cadherin and β-catenin were significantly reduced. When MDA-MB-231 cells expressing shRNA were injected in vivo into BALB/c nu/nu nude mice, a significant reduction in the number of colonies that formed in the lungs was observed. Taken together, the results show that NAT1 can alter the invasion and metastatic properties of some triple-negative breast cancer cells but not all. The study suggests that NAT1 may be a novel therapeutic target in a subset of breast cancers.
authors: School of Biomedical Sciences, University of Queensland, St Lucia, Queensland, 4072, Australia.
authors: Jacky M
authors: JM
authors: Tiang
authors: Neville J
authors: NJ
authors: Butcher
authors: Rodney F
authors: RF
authors: Minchin
mesh_terms: D000818:Animals; D001191:Arylamine N-Acetyltransferase / Q000172:deficiency / Q000502:physiology*; D015820:Cadherins / Q000378:metabolism; D045744:Cell Line, Tumor; D005260:Female; D055785:Gene Knockdown Techniques; D006801:Humans; D007527:Isoenzymes / Q000172:deficiency / Q000502:physiology*; D016086:Lentivirus; D008175:Lung Neoplasms / Q000556:secondary; D008807:Mice, Inbred BALB C; D008819:Mice, Nude; D009361:Neoplasm Invasiveness; D009368:Neoplasm Transplantation; D011554:Pseudopodia / Q000502:physiology; D000071250:Snail Family Transcription Factors; D014157:Transcription Factors / Q000378:metabolism; D014161:Transduction, Genetic; D064726:Triple Negative Breast Neoplasms / Q000201:enzymology* / Q000473:pathology; D014407:Tumor Cells, Cultured; D051176:beta Catenin / Q000378:metabolism
chemical_list: D015820:Cadherins; D007527:Isoenzymes; D000071250:Snail Family Transcription Factors; D014157:Transcription Factors; D051176:beta Catenin; D001191:Arylamine N-Acetyltransferase; C089384:N-acetyltransferase 1
keywords: Filopodia; MDA-MB-231; N-acetyltransferase; invasion; metastasis
references: Biochim Biophys Acta. 2010 Apr;1803(4):520-5
references: 20144902
references: Hum Mol Genet. 2000 Oct;9(16):2435-41
references: 11005799
references: J Biol Chem. 2003 Sep 12;278(37):35086-92
references: 12832400
references: Mol Cancer Res. 2003 Sep;1(11):826-35
references: 14517345
references: Nucleic Acids Res. 2003 Dec 15;31(24):7280-301
references: 14654704
references: Breast Cancer Res Treat. 2004 Feb;83(3):249-89
references: 14758095
references: J Biol Chem. 2004 Feb 27;279(9):7708-14
references: 14672957
references: J Biol Chem. 2004 May 21;279(21):22131-7
references: 15039438
references: Proc Natl Acad Sci U S A. 2004 Aug 24;101(34):12682-7
references: 15314234
references: Int J Dev Biol. 2004;48(5-6):463-76
references: 15349821
references: J Cell Sci. 2004 Sep 15;117(Pt 20):4691-703
references: 15331629
references: Int J Cancer. 1989 Jul 15;44(1):17-22
references: 2744888
references: Carcinogenesis. 1991 Aug;12(8):1465-9
references: 1860167
references: Biochem J. 1995 Apr 1;307 ( Pt 1):1-3
references: 7717963
references: Curr Opin Genet Dev. 2005 Feb;15(1):87-96
references: 15661538
references: Cell. 2005 May 20;121(4):579-91
references: 15907471
references: Biophys J. 2005 Aug;89(2):782-95
references: 15879474
references: FEBS Lett. 2005 Aug 29;579(21):4719-23
references: 16098511
references: Mol Cell. 2006 Aug;23(4):607-18
references: 16916647
references: Clin Cancer Res. 2006 Nov 1;12(21):6459-68
references: 17085660
references: Cancer Res. 2007 Jan 1;67(1):85-92
references: 17210686
references: Anticancer Drugs. 2007 Jun;18(5):563-8
references: 17414625
references: Int J Biochem Cell Biol. 2007;39(11):1999-2005
references: 17392017
references: Cell Mol Life Sci. 2007 Dec;64(24):3201-18
references: 17957337
references: Mol Pharmacol. 2008 Jun;73(6):1761-8
references: 18310302
references: FEBS Lett. 2008 Jun 18;582(14):2102-11
references: 18396168
references: Dev Cell. 2008 Jun;14(6):818-29
references: 18539112
references: Cancer Metastasis Rev. 2009 Jun;28(1-2):151-66
references: 19153669
references: Mol Oncol. 2007 Jun;1(1):84-96
references: 18516279
references: Cancer Epidemiol Biomarkers Prev. 2000 Jan;9(1):29-42
references: 10667461
references: J Cell Biol. 2000 Feb 21;148(4):779-90
references: 10684258
references: Carcinogenesis. 2000 Jul;21(7):1453-6
references: 10874025
references: Mol Cancer Ther. 2009 Jul;8(7):2027-35
references: 19509275
references: J Cell Sci. 2010 Oct 15;123(Pt 20):3507-14
references: 20841377
references: J Mol Med (Berl). 2010 Nov;88(11):1123-31
references: 20628863
references: J Biomed Biotechnol. 2011;2011:970382
references: 21151618
references: Neoplasia. 2010 Dec;12(12):1066-80
references: 21170270
references: PLoS One. 2011;6(2):e17031
references: 21347396
references: Nat Struct Biol. 2000 Jul;7(7):560-4
references: 10876241
references: J Clin Invest. 2011 Jul;121(7):2750-67
references: 21633166
references: Pharmacol Rev. 2012 Jan;64(1):147-65
references: 22090474
references: Cancer Metastasis Rev. 2012 Dec;31(3-4):469-78
references: 22729277
references: Biochim Biophys Acta. 2013 Apr;1830(4):3067-76
references: 23333633
references: BMC Cancer. 2013;13:326
references: 23819905
references: PLoS One. 2013;8(10):e77923
references: 24205029
references: FEBS J. 2009 Sep;276(17):4900-8
references: 19664055
references: Mol Cell Proteomics. 2009 Oct;8(10):2308-20
references: 19620624
references: Cell. 2009 Oct 30;139(3):610-22
references: 19879846
references: Biochem Biophys Res Commun. 2010 Feb 26;393(1):95-100
references: 20100460
references: Mol Pharmacol. 2003 Jul;64(1):170-9
references: 12815173